John J. Oppenheimer Reports No Securities Owned in bioAffinity Technologies, Inc.

John J. Oppenheimer, a director of bioAffinity Technologies, Inc., has reported that he owns no securities in the company as of August 12, 2025. The filing, submitted on September 25, 2025, indicates that Oppenheimer holds no shares or other securities in bioAffinity Technologies, Inc. This information is disclosed in accordance with SEC regulations, which require directors and officers to report their ownership of company securities. The filing does not indicate any changes in ownership or transactions involving securities.